Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer.

Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Abstract Text:

    q wangQ Wang,m williamsonM Williamson,s bottS Bott,n brookman-amissahN Brookman-Amissah,a freemanA Freeman,j nariculamJ Nariculam,m j f hubankM J F Hubank,a ahmedA Ahmed,j r mastersJ R Masters,

    Oligoarray analysis of a matched pair of prostate cancer and normal cell lines derived from the same radical prostatectomy specimen identified 113 candidate hypomethylated genes that were overexpressed in the cancer cells and contained CpG islands. Hypomethylation of wingless-related MMTV integration site 5A (WNT5A), S100 calcium-binding protein P (S100P) and cysteine-rich protein 1(CRIP1) was confirmed in the cancer cells by bisulfite sequencing. Treatment of the corresponding normal prostate epithelial cells 1542-NPTX with the DNA methyltransferase inhibitor 5-Aza-2'-deoxycytidine (5-aza-CdR) induced higher levels of mRNA expression and partial loss of methylation on these genes. Primary prostate cancers were tested using methylation-specific polymerase chain reaction. WNT5A was hypomethylated in 11/17 (65%) tumors, S100P in 8/16 (50%) and CRIP1 in 13/20 (65%). Bisulfite sequencing of a section of the 5' untranslated region (UTR) of WNT5A revealed that three CpG sites (15, 24 and 35) were consistently methylated (93%) in the normal cell line and normal tissues, but not in the prostate cancer cell line and eight primary prostate cancers. Multiple putative binding sites for the transcription factors SP1 and AP-2 were found adjacent to CpG sites 15 and 24. A putative c-Myb binding site was located within the CpG site 35. Anti-c-Myb antibody co-precipitation with WNT5A was methylation-sensitive in 1542-NPTX cells. It is likely that an epigenetic mechanism regulates WNT5A expression in prostate cancer.

    Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Publishing Authors By Initials

    q wangQ Wang,m williamsonM Williamson,s bottS Bott,n brookman-amissahN Brookman-Amissah,a freemanA Freeman,j nariculamJ Nariculam,mj hubankMJ Hubank,a ahmedA Ahmed,jr mastersJR Masters,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Oncogene

    VOLUME: 26

    Page Numbers: 6560-5

    Journal Abbreviation: Oncogene

    ISSN: 0950-9232

    DAY: 7

    MONTH: 05

    YEAR: 2007

    Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8711562

    Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer.

    AFFILIATION: Prostate Cancer Research Centre, Institute of Urology and Nephrology, University College London, and Department of Histopathology, University College London Hospitals Trust, UK.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Oncogene

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News